Healthcare / BiotechnologyUpdated 2026-05-10 22:07 UTC

TLV/ORMP stock hub

TLV/ORMP has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

TLV/ORMPis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

479.6M

Tel Aviv Stock Exchange

Market data

Live price

Current market quote for this ticker.

Current price

TLV/ORMP

In the news

Latest news · TLV/ORMP

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 n/aP50 n/aP75 n/a

Trailing P/E2.4

P25 n/aP50 n/aP75 n/a

ROE37.1

P25 n/aP50 n/aP75 n/a

ROIC-17.9

P25 n/aP50 n/aP75 n/a

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All TLV/ORMP market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

179

Groups with data

Currency

USD

Showing 179 of 179 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	United States
Country code	IL
Employees	4
Enterprise value	ILA 92.7M
Exchange	Tel Aviv Stock Exchange
Financial currency	USD
First seen	2026-05-10
Industry	Biotechnology
Isin	US68403P2039
Last refreshed	2026-05-10
Market cap	ILA 479.6M
Price	ILA 1,179
Price currency	ILA
Rev Per Employee	1,594,000x
Sector	Healthcare
Sic	2836
Symbol	tlv/ORMP
Website	https://oramed.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	42.04%
EV Earnings	0.46x
EV/FCF	-3.18x
EV/Sales	15.99x
FCF yield	-6.09%
P/B ratio	0.75x
P/E ratio	2.38x
P/S ratio	75.21x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
Gross margin	0.65%
Gross Profit	ILA 41,444
Gross Profit Growth3 Y	-83.12%
Gross Profit Growth5 Y	-65.63%
Net Income	ILA 201.6M
Net Income Growth Quarters	3%
Net Income Growth Years	2%
Pretax Margin	3,766.2%
Profit Margin	3,202.5%
Profit Per Employee	ILA 50.4M
Profitable Years	1
ROA	-4.88
ROCE	-7.12
ROE	37.1
ROIC	-17.91
Roic5y	-157

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	57.77%
Cagr3y	7.12%
Cagr5y	-18.08%
EPS Growth Quarters	3
EPS Growth Years	2
Revenue Growth Years	0x
Revenue Growth3 Y	-9.55x
Revenue Growth5 Y	-5.91x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	ILA 0.01
Assets	ILA 736M
Cash	ILA 401.4M
Current Assets	ILA 386.6M
Current Liabilities	ILA 55.4M
Debt	ILA 2.6M
Debt Equity	ILA 0
Debt FCF	ILA -0.09
Equity	ILA 636.8M
Liabilities	ILA 99.2M
Long Term Assets	ILA 349.4M
Long Term Liabilities	ILA 43.8M
Net Cash	ILA 425.4M
Net Cash By Market Cap	ILA 88.71
Net Cash Growth	-5.73%
Net Debt Equity	ILA -0.67
Tangible Book Value	ILA 636.8M
Tangible Book Value Per Share	ILA 16.21
WACC	11.14

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	6.98
Net Working Capital	ILA -36.4M
Quick ratio	6.62
Working Capital	ILA 364M
Working Capital Turnover	ILA 0.05

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-3.84%
Dividend Growth	0%
Dividend Growth Years	0%
Dividend per share	ILA 0.79
Dividend Years	1
Dividend Yield	6.75%
Ex Div Date	2026-01-16
Last Dividend	ILA 0.79

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	57.72%
200-day SMA	911.1
3Y total return	22.9%
50-day SMA	1,099.3
50-day SMA vs 200-day SMA	50over200
5Y total return	-63.11%
All Time High	9,856
All Time High Change	-88.04%
All Time High Date	2021-11-03
All Time Low	653.7
All Time Low Change	80.36%
All Time Low Date	2023-01-29
ATR	49.91
Beta	1.26
Ch YTD	30.75
High	1,198
High52	1,247
High52 Date	2026-04-28
High52ch	-5.45%
Low	1,171
Low52	680
Low52 Date	2025-08-13
Low52ch	73.38%
Ma50ch	7.25%
Price vs 200-day SMA	29.41%
RSI	56.83
RSI Monthly	55.36
RSI Weekly	58.24
Sharpe ratio	1.1x
Sortino ratio	1.99
Total Return	2.91%
Tr YTD	40.53
Tr1m	11.44%
Tr1w	2.52%
Tr3m	17.08%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	ILA -48.1M
Operating margin	-754.4

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	30,205,167%
Shares Insiders	17.49%
Shares Institutions	20.37%
Shares Qo Q	-4.37%
Shares Yo Y	3.84%
Short Ratio	4.2

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	ILA -48.3M
Average Volume	6,572.1x
Bv Per Share	16.21
CAPEX	ILA -28,692
Ch1m	11.44
Ch1w	2.52
Ch1y	46.75
Ch3m	17.08
Ch3y	14.36
Ch5y	-65.68
Ch6m	66.76
Change	0.6%
Change From Open	0.6
Close	1,172
Days Gap	0
Depreciation Amortization	351,021
Dollar Volume	542,340
Earnings Date	2026-04-02
EBIT	ILA -48.1M
EBITDA	ILA -47.7M
EPS	ILA 4.78
F Score	1
FCF	ILA -29.2M
FCF EV Yield	-31.47x
Financing CF	-15,114,308
Fiscal Year End	December
Founded	2,002
Graham Number	4178.43859
Graham Upside	254.4
Income Tax	ILA 36M
Investing CF	17,352,284
Is Primary Listing	0
Last Earnings Date	2025-11-07
Last Report Date	2025-12-31
Ma150	972
Ma150ch	21.29%
Ma20	1,153.3
Ma20ch	2.23%
Net CF	-27,011,924
Open	1,172
Payment Date	2026-01-26
Position In Range	29.63
Ppne	3,875,736
Price Date	2026-05-08
Ptbv Ratio	0.75
Relative Volume	0.07x
Revenue	6,376,000x
SBC By Revenue	299.6x
Share Based Comp	19,102,496
Tax By Revenue	565.4x
Tax Rate	15.01%
Tr6m	79.23%
Volume	460
Z Score	1.46

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

TLV/ORMP dividend yield, growth & safety

Yield, payout sustainability, and the multi-year growth streak.

Dividend yield

+6.8%

$0.79 annual per share

Payout ratio

n/a

Share of earnings returned as dividends. Below 60% is generally sustainable.

5Y dividend CAGR

n/a

0 consecutive years of growth

Total shareholder yield

+2.9%

Next ex-dividend date: 2026-01-16

Performance

TLV/ORMP stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns TLV/ORMP?

Insider, institutional, and short-interest positioning.

Institutional ownership

+20.4%

Share of float held by funds and institutions

Insider ownership

+17.5%

Stake held by company insiders. Higher generally signals alignment.

Negative means the company is buying back shares.

Technical

TLV/ORMP momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

56.8

Neutral momentum band

Price vs 200-day MA

+29.4%

50/200-day relationship not available

Beta (5Y)

1.26

More volatile than the market

Sharpe ratio

1.10

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About TLV/ORMP

Hub-level FAQ points readers to the deeper analysis pages.

What is the current tlv/ORMP stock rating?

tlv/ORMP is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full tlv/ORMP analysis?

The full report lives at /stocks/tlv/ORMP/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for tlv/ORMP?

The latest report frames tlv/ORMP around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the tlv/ORMP page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.